As of Monday, more Americans received at least one dose of the COVID-19 vaccine than tested positive for the disease, according to the Bloomberg Vaccine Tracker.
Bloomberg vaccine data shows that 26.5 million Americans have received one or more doses of the vaccine, outnumbering almost 26.3 million coronavirus cases that Johns Hopkins University recorded.
The Bloomberg Vaccine Tracker determined that the United States is vaccinating people at a higher rate than any other country, with about 1.34 million injections administered per day.
Since the Pfizer-BioNTech vaccine became the first vaccine available in the U.S. last month, followed by the Modern vaccine, nearly 7.8 percent of Americans have received one or more doses of a vaccine and 1.8 percent, or 5.82 million, received the two necessary doses.
According to Bloomberg, three other nations have reached the mark of having more vaccinations than confirmed cases before the USA: Israel, the United Kingdom and the United Arab Emirates, although the actual number of so many remain unidentified.
In the United States, deaths and hospitalizations reached unprecedented levels in January and have only begun to decline.
Vaccination brings the country closer to collective immunity, which prevents the spread of the virus. Health experts, including America’s leading infectious disease specialist Anthony Fauci
Anthony FauciFauci says the Johnson & Johnson vaccine is useful in the fight against COVID-19, despite its lesser effectiveness. Proper use of PCR is necessary for a focused response to the pandemic Fauci expects to see vaccinations for children in ‘late spring and early summer’ MORE, estimate that between 70% and 85% of the American population needs to be vaccinated to reach this point.
Countries around the world are currently dealing with variants of COVID-19, found for the first time in the United Kingdom and South Africa, which are believed to be more contagious than the original strain. Initial studies of the Pfizer-BioNTech vaccine suggested that it is still effective against mutations in these strains.